Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2004 12
2007 2
2008 1
2009 2
2010 1
2011 1
2012 1
2013 1
2014 1
2015 1
2016 1
2017 3
2018 3
2019 2
2020 3
2021 3
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean paulus cicenas (1 results)?
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC.
Simiene J, Dabkeviciene D, Stanciute D, Prokarenkaite R, Jablonskiene V, Askinis R, Normantaite K, Cicenas S, Suziedelis K. Simiene J, et al. Among authors: cicenas s. BMC Cancer. 2023 Sep 12;23(1):857. doi: 10.1186/s12885-023-11365-5. BMC Cancer. 2023. PMID: 37697308 Free PMC article.
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Keller SM, Samkari A, Spicer JD; KEYNOTE-671 Investigators. Wakelee H, et al. N Engl J Med. 2023 Aug 10;389(6):491-503. doi: 10.1056/NEJMoa2302983. Epub 2023 Jun 3. N Engl J Med. 2023. PMID: 37272513 Clinical Trial.
Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials.
Eide IJZ, Stensgaard S, Helland Å, Ekman S, Mellemgaard A, Hansen KH, Cicenas S, Koivunen J, Grønberg BH, Sørensen BS, Brustugun OT. Eide IJZ, et al. Among authors: cicenas s. Transl Lung Cancer Res. 2022 Jun;11(6):953-963. doi: 10.21037/tlcr-21-995. Transl Lung Cancer Res. 2022. PMID: 35832438 Free PMC article.
The Impact of the COVID-19 Pandemic on Cancer Patient's Management-Lithuanian Cancer Center Experience.
Dabkeviciene D, Vincerzevskiene I, Urbonas V, Venius J, Dulskas A, Brasiuniene B, Janulionis E, Burneckis A, Zileviciene A, Tiskevicius S, Vanseviciute-Petkeviciene R, Usinskiene J, Briediene R, Bulotiene G, Stratilatovas E, Ostapenko V, Gibaviciene J, Karnas I, Kekstaite S, Navickiene J, Ulys A, Zalimas A, Sruogis A, Kardelis Z, Zaremba S, Askinis R, Cicenas S, Tikuisis R, Ciurliene R, Jarmalaite S. Dabkeviciene D, et al. Among authors: cicenas s. Healthcare (Basel). 2021 Nov 9;9(11):1522. doi: 10.3390/healthcare9111522. Healthcare (Basel). 2021. PMID: 34828568 Free PMC article.
Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study.
Eide IJZ, Grut H, Helland Å, Ekman S, Sørensen JB, Hansen KH, Grønberg BH, Cicenas S, Koivunen JP, Mellemgaard A, Brustugun OT. Eide IJZ, et al. Among authors: cicenas s. Acta Oncol. 2021 Dec;60(12):1565-1571. doi: 10.1080/0284186X.2021.1973092. Epub 2021 Sep 6. Acta Oncol. 2021. PMID: 34486915 Clinical Trial.
A Pilot Study of Safer Radiation Dosage to the Heart and Its Subregions.
Steponavičienė R, Jonušas J, Griškevičius R, Venius J, Cicėnas S. Steponavičienė R, et al. Among authors: cicenas s. Medicina (Kaunas). 2021 Mar 31;57(4):320. doi: 10.3390/medicina57040320. Medicina (Kaunas). 2021. PMID: 33807209 Free PMC article.
Lung Cancer in Lithuania.
Gedvilaitė V, Danila E, Cicėnas S, Smailytė G. Gedvilaitė V, et al. Among authors: cicenas s. J Thorac Oncol. 2020 Sep;15(9):1401-1405. doi: 10.1016/j.jtho.2020.02.029. J Thorac Oncol. 2020. PMID: 32854913 Free article. No abstract available.
46 results